Table 3.
Inhibition studies of the chimeric species A1 and A2 of human arginase type I.
| Substrate | Inhibitor | Inhibition Type | Kis (mM) | |
|---|---|---|---|---|
| WT-arginase | Arginine | Guanidine | Competitive | 56 ± 4 |
| Chimera A1 | Arginine |
|
Competitive | 38 ± 6 |
| Chimera A2 | Agmatine | Competitive | 40 ± 6 | |
| WT-arginase | Arginine | Agmatine | Competitive | 42 ± 5 |
| Chimera A1 | Arginine |
|
Competitive | 27 ± 2 |
| WT-arginase | Arginine | Ornithine | Competitive | 2 ± 0.5 |
| Chimera A1 | Arginine |
|
Competitive | 60 ± 2 |
| Chimera A2 | Agmatine | Arginine | Competitive | 9 ± 3 |
|
The values of the kinetic parameters indicated in this table correspond to the results of two experiments performed in duplicate and the standard deviations were not greater than 5%. Chimeric species: A1 (I129T/N130Y/131A mutations); A2 (I129T/N130Y/T131A-∆P132-T134).